News
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
EQS-News: Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
SoFi Technologies, Inc. Announces Pricing of Public Offering of Common Stock
SoFi Technologies, Inc. (NASDAQ: SOFI) (“SoFi” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 54,545,454 shares of its common stock at
SoFi Technologies, Inc. Announces Public Offering of Common Stock
SoFi Technologies, Inc. (NASDAQ: SOFI) (“SoFi” or the “Company”) today announced an underwritten public offering of $1.5 billion of shares of its common stock. In connection with the offering, SoFi
EPR Properties Announces $113 Million in Sale Leaseback Transactions
EPR Properties (NYSE:EPR) (the “Company”) today announced the acquisition and leaseback of a five-property portfolio of championship golf courses, along with the acquisition and leaseback of the
VICI Properties Inc. Declares Regular Quarterly Dividend
VICI Properties Inc. (NYSE: VICI) (“VICI Properties”) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.45 per share of common stock for the period
Cirrus Logic to Present at Upcoming Conference
Cirrus Logic, Inc. (Nasdaq: CRUS) announced that President and Chief Executive Officer John Forsyth and Chief Financial Officer Jeff Woolard will present at the Barclays Annual Global Technology
EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance